Total Payments
$19,605
2024 Payments
$2,064
Companies
57
Transactions
1,307
Medicare Patients
2,961
Medicare Billing
$174,897
Payment Breakdown by Category
Food & Beverage$19,434 (99.1%)
Education$171.74 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,434 | 1,296 | 99.1% |
| Education | $171.74 | 11 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,176 | 130 | $0 (2024) |
| Novo Nordisk Inc | $2,125 | 142 | $0 (2024) |
| PFIZER INC. | $1,500 | 126 | $0 (2024) |
| Lilly USA, LLC | $1,301 | 86 | $0 (2024) |
| Amarin Pharma Inc. | $1,227 | 82 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,135 | 100 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,050 | 57 | $0 (2024) |
| Astellas Pharma US Inc | $891.86 | 50 | $0 (2024) |
| Amgen Inc. | $861.37 | 59 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $744.88 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,064 | 136 | ABBVIE INC. ($348.22) |
| 2023 | $2,598 | 170 | ABBVIE INC. ($524.13) |
| 2022 | $2,785 | 159 | ABBVIE INC. ($458.67) |
| 2021 | $3,044 | 179 | AbbVie Inc. ($563.11) |
| 2020 | $1,990 | 131 | Lilly USA, LLC ($303.92) |
| 2019 | $1,998 | 153 | Amarin Pharma Inc. ($230.66) |
| 2018 | $2,231 | 163 | Novo Nordisk Inc ($425.47) |
| 2017 | $2,896 | 216 | Allergan Inc. ($381.40) |
All Payment Transactions
1,307 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: PAIN | ||||||
| 12/04/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Diabetes | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Oncology | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Obesity | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Biological | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 760 | 1,071 | $175,070 | $48,076 |
| 2022 | 13 | 685 | 942 | $126,238 | $28,401 |
| 2021 | 14 | 720 | 992 | $126,322 | $50,698 |
| 2020 | 16 | 796 | 1,057 | $121,194 | $47,723 |
Total Patients
2,961
Total Services
4,062
Medicare Billing
$174,897
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 57 | 57 | $27,930 | $16,115 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 252 | $58,968 | $11,317 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 245 | $40,425 | $9,868 | 24.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 45 | 45 | $6,480 | $3,411 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $31,178 | $2,352 | 7.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 57 | 57 | $2,736 | $1,674 | 61.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 75 | 160 | $4,160 | $1,498 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $2,400 | $1,468 | 61.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 55 | 55 | $660.00 | $330.79 | 50.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 19 | $133.00 | $41.80 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 239 | $55,926 | $10,438 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 174 | $28,710 | $7,038 | 24.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 51 | 51 | $6,600 | $3,496 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 56 | $2,688 | $1,566 | 58.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 77 | 77 | $2,387 | $1,343 | 56.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 62 | 62 | $1,922 | $1,102 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 87 | 87 | $20,706 | $1,043 | 5.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 102 | $2,652 | $977.77 | 36.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 12 | 12 | $1,860 | $522.98 | 28.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 16 | $1,888 | $487.29 | 25.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 32 | 32 | $384.00 | $198.76 | 51.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 13 | 15 | $382.00 | $146.18 | 38.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 19 | $133.00 | $42.13 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 258 | $59,760 | $20,966 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 76 | 76 | $17,158 | $9,778 | 57.0% |
About Dr. Muhamad Musa, M.D
Dr. Muhamad Musa, M.D is a Family Medicine healthcare provider based in Cuyahoga Falls, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1588893960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhamad Musa, M.D has received a total of $19,605 in payments from pharmaceutical and medical device companies, with $2,064 received in 2024. These payments were reported across 1,307 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($19,434).
As a Medicare-enrolled provider, Musa has provided services to 2,961 Medicare beneficiaries, totaling 4,062 services with total Medicare billing of $174,897. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cuyahoga Falls, OH
- Active Since 07/07/2009
- Last Updated 05/31/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1588893960
Products in Payments
- Vascepa (Drug) $1,227
- VRAYLAR (Drug) $1,173
- Ozempic (Drug) $765.09
- UBRELVY (Drug) $693.98
- FARXIGA (Drug) $674.24
- NURTEC ODT (Drug) $549.45
- JARDIANCE (Drug) $537.90
- XIFAXAN (Drug) $529.48
- TRELEGY ELLIPTA (Drug) $480.44
- Kerendia (Drug) $441.29
- XARELTO (Drug) $406.34
- ENTRESTO (Drug) $395.60
- TRULICITY (Drug) $384.34
- Aimovig (Biological) $378.09
- ELIQUIS (Drug) $370.81
- Victoza (Drug) $276.41
- MOUNJARO (Drug) $274.07
- CHANTIX (Drug) $266.54
- Myrbetriq (Drug) $263.90
- Prolia (Biological) $263.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cuyahoga Falls
Dr. Tricia Bedrick, D.o, D.O
Family Medicine — Payments: $223,294
Family Medicine $223,294
Dr. Scott Higley, D.o, D.O
Family Medicine — Payments: $16,424
Family Medicine $16,424
William Schukay, Do, DO
Family Medicine — Payments: $16,108
Family Medicine $16,108
James Johnston, D.o, D.O
Family Medicine — Payments: $15,241
Family Medicine $15,241
Victoria Digennaro, D.o, D.O
Family Medicine — Payments: $13,874
Family Medicine $13,874
Andrea Cerone, M.d, M.D
Family Medicine — Payments: $12,005
Family Medicine $12,005